Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107573276A reveals NHC-catalyzed indolinone synthesis. High yield, mild conditions offer cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel mild preparation of antineoplastic drug tegafur using 2-benzoyloxy tetrahydrofuran. High yield, >99.7% purity, scalable industrial process.
Patent CN109134392A reveals a mild synthetic route for N2-alkenyl benzotriazoles. Achieve high selectivity and cost reduction in fine chemical manufacturing with scalable processes.
Novel one-step Lewis acid catalysis improves vinpocetin yield to 90% with >99% purity, offering significant supply chain stability and cost efficiency for global buyers.
Novel epoxidation rearrangement process enables high-purity fluorinated ketone production with reduced environmental impact and scalable manufacturing capabilities for global supply chains.
Novel one-pot method for Pantoprazole Sodium reduces impurities and costs. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Novel one-step method using azlactones offers high yield and mild conditions for reliable dihydroquinolinone supplier operations.
Patent CN106565411A reveals high-selectivity o-chlorotoluene production. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Patent CN105777740B reveals a streamlined four-step route for isavuconazole, offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN104402752A reveals high purity synthesis route. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Patent CN112812040B details a visible-light mediated route to high-purity guanylhydrazone derivatives, offering significant cost reduction in organic synthesis manufacturing.
Novel preparation method reduces steps and cost. Reliable supply chain for API manufacturing. High-purity Oseltamivir Phosphate production via patented Ritter reaction route.
Patent CN115433103B reveals ionic liquid catalyst method. Eliminates acid neutralization, reduces waste, ensures supply continuity for global buyers.
Advanced phase-transfer catalysis patent ensures high purity fluoro-carbonate ester production with significant cost reduction and supply chain reliability for battery manufacturers.
Patent CN114502527B enables high purity sevoflurane production. Reduces impurity C significantly. Offers cost reduction in API intermediate manufacturing for global supply chains.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN116606268A reveals high-yield furanone synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with green catalytic methods for global supply chains.
Patent CN114702471B details green synthesis for Caronic Anhydride. Enhances yield and safety for pharmaceutical intermediates supply chain.
Patent CN112778238A details a novel Ir/Co dual-catalytic amidation method. This green chemistry approach eliminates stoichiometric coupling reagents, offering significant cost reduction and supply chain reliability for high-purity amide manufacturing.
Discover a novel dual-catalytic method for amide bond formation from carboxylic acids using blue light irradiation. Achieve cost reduction in pharmaceutical intermediate manufacturing with high atom economy.